.Attributes Medication, Published online: 16 September 2024 doi:10.1038/ s41591-024-03244-8In the observational SCRUM-Japan GOZILA research, after a typical consequence of 11 months, individuals with metastatic intestinal lumps who obtained biomarker-matched treatments based upon distributing tumor DNA profiling showed a greater scientific benefit than those getting unrivaled treatment.